--- title: "BioStem Technologies (BSEM) news: offering" url: "https://aibio.space/companies/biostem-technologies/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "BSEM offering news: BioStem Technologies prices $3 million private placement at $4.08 per share. BioStem Technologies, Inc. (NASDAQ: BSEM), United States." --- BSEM BioStem Technologies, Inc. NASDAQ · United States # BioStem Technologies (BSEM) news BSEM offering news Financings · 2026-09-30 ## [BioStem Technologies prices $3 million private placement at $4.08 per share](https://aibio.space/news/biostem-technologies-prices-3-million-private-placement-4-08-share/) BioStem Technologies has agreed to issue 735,296 shares at $4.08 each in a private placement, with Series A and Series B warrants for the same number of shares at $3.83. The company expects gross proceeds of about $3 million, and about $5.6 million more if all the warrants are exercised for cash. ## Latest BioStem Technologies news 1. 2026-09-18 Financings [BioStem Technologies signs committed equity facility to sell up to $40,000,000 of stock to Roth](https://aibio.space/news/biostem-technologies-signs-committed-equity-facility-sell-up-40-000/) BioStem (Nasdaq: BSEM) may sell shares to Roth Principal Investments over up to 36 months at a 3.0% or 5.0% discount to average price. The company pays a $400,000 cash commitment fee. ## BioStem Technologies at a glance - **Ticker**: BSEM - **Listing**: NASDAQ - **Country**: United States ### Related companies - [VirExit Technologies](https://aibio.space/companies/virexit-technologies/) OTC: VXIT - [Mosaic ImmunoEngineering](https://aibio.space/companies/mosaic-immunoengineering/) OTC: CPMV - [Entrada Therapeutics](https://aibio.space/companies/entrada-therapeutics/) NASDAQ: TRDA - [CAMP4 Therapeutics](https://aibio.space/companies/camp4-therapeutics/) NASDAQ: CAMP - [ADMA Biologics](https://aibio.space/companies/adma-biologics/) NASDAQ: ADMA - [Marker Therapeutics](https://aibio.space/companies/marker-therapeutics/) NASDAQ: MRKR - [Crescent Biopharma](https://aibio.space/companies/crescent-biopharma/) NASDAQ: CBIO - [Estrella Immunopharma](https://aibio.space/companies/estrella-immunopharma/) NASDAQ: ESLA ### Also on NASDAQ - [Tenon Medical](https://aibio.space/companies/tenon-medical/) TNON - [Aclaris Therapeutics](https://aibio.space/companies/aclaris-therapeutics/) ACRS - [Rein Therapeutics](https://aibio.space/companies/rein-therapeutics/) RNTX - [KALA BIO](https://aibio.space/companies/kala-bio/) KALA - [OnKure Therapeutics](https://aibio.space/companies/onkure-therapeutics/) OKUR - [Tyra Biosciences](https://aibio.space/companies/tyra-biosciences/) TYRA ## Questions about BioStem Technologies Has BioStem Technologies raised money recently? Our latest story on this, dated Sep 30, 2026: "BioStem Technologies prices $3 million private placement at $4.08 per share". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/biostem-technologies-prices-3-million-private-placement-4-08-share/). What is the ticker symbol of BioStem Technologies? BioStem Technologies, Inc. trades under the ticker BSEM on NASDAQ. Where is BioStem Technologies listed? BioStem Technologies, Inc. is listed on NASDAQ. What is the SEC CIK of BioStem Technologies? The SEC Central Index Key (CIK) for BioStem Technologies, Inc. is 1658678. Its filings are on SEC EDGAR. How many shares does BioStem Technologies have outstanding? 17,849,471 shares as of 2026-08-12, per the cover page of its 10-Q filed 2026-08-12. Which country or territory is BioStem Technologies listed under? Our directory records BioStem Technologies, Inc. under United States. What does BioStem Technologies do? Our directory classifies BioStem Technologies, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of BioStem Technologies? The ISIN recorded for BioStem Technologies, Inc. is US0906842002. Does aibio.space cover BioStem Technologies? aibio.space lists BioStem Technologies, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is BioStem Technologies incorporated? SEC records list its state or country of incorporation as FL. What is the latest BioStem Technologies (BSEM) stock news? Our latest story on BioStem Technologies, dated Sep 30, 2026: "BioStem Technologies prices $3 million private placement at $4.08 per share". BioStem Technologies has agreed to issue 735,296 shares at $4.08 each in a private placement, with Series A and Series B warrants for the same number of shares at $3.83. The company expects gross proceeds of about $3 million, and about $5.6 million more if all the warrants are exercised for cash. [Source](https://aibio.space/news/biostem-technologies-prices-3-million-private-placement-4-08-share/). How long will BioStem Technologies's cash last? From our story of Sep 30, 2026: The company and its going-concern warning [Source](https://aibio.space/news/biostem-technologies-prices-3-million-private-placement-4-08-share/). How much cash does BioStem Technologies have? From our story of Sep 30, 2026: For the six months ended June 30, 2026 it reports a net loss of $17,791,065 and net cash used in operating activities of $6,363,977, with cash of $6,962,492 at the end of the period, down from $30,843,880 a year earlier. [Source](https://aibio.space/news/biostem-technologies-prices-3-million-private-placement-4-08-share/). Is BioStem Technologies a smaller reporting company? SEC records list BioStem Technologies, Inc.'s filer category as: Non-accelerated filer
Smaller reporting company
Emerging growth company. Where is BioStem Technologies headquartered? SEC records list its business address as 2836 CENTER PORT CIRCLE, POMPANO BEACH, FL, 33604. ## Investor discussion: BioStem Technologies Members talk about BioStem Technologies (BSEM). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at BioStem Technologies, newest first. Each line links the filing it comes from. 1. 2026-09-30 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.02,7.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1658678/000119312526409169/bsem-ex99_1.htm) 2. 2026-09-18 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1658678/000119312526395556/bsem-ex99_1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:BSEM on TradingView](https://www.tradingview.com/symbols/NASDAQ-BSEM/). ## SEC filings and registration - **SEC name**: BioStem Technologies, Inc. - **CIK**: 1658678 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: BSEM (Nasdaq) - **State or country of incorporation**: FL - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company
Emerging growth company - **Business address**: 2836 CENTER PORT CIRCLE, POMPANO BEACH, FL, 33604 - **Phone**: 954-380-8342 - **Shares outstanding**: 17,849,471 as of 2026-08-12 (10-Q filed 2026-08-12) - **Former names**: BIOSTEM TECHNOLOGIES ### Recent filings (8-K and 6-K are the company's own announcements) - [S-1](https://www.sec.gov/Archives/edgar/data/1658678/000121390026106555/ea0307473-s1_biostem.htm) filed 2026-10-02 - [8-K](https://www.sec.gov/Archives/edgar/data/1658678/000119312526409169/bsem-20260929.htm) filed 2026-09-30 - [S-1](https://www.sec.gov/Archives/edgar/data/1658678/000121390026101505/ea0305059-s1_biostem.htm) filed 2026-09-18 - [8-K](https://www.sec.gov/Archives/edgar/data/1658678/000119312526395556/bsem-20260918.htm) filed 2026-09-18 - [8-K](https://www.sec.gov/Archives/edgar/data/1658678/000119312526347211/bsem-20260812.htm) filed 2026-08-12 - [10-Q](https://www.sec.gov/Archives/edgar/data/1658678/000119312526347096/bsem-20260630.htm) filed 2026-08-12 - [8-K](https://www.sec.gov/Archives/edgar/data/1658678/000119312526340271/bsem-20260806.htm) filed 2026-08-07 - [S-1](https://www.sec.gov/Archives/edgar/data/1658678/000121390026082719/ea0299458-s1_biostem.htm) filed 2026-07-29 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001658678), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details BioStem Technologies, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BSEM, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: BioStem Technologies, Inc. - **Ticker**: BSEM - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US0906842002 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-BSEM/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/biostem-technologies/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "BioStem Technologies (BSEM) news: offering", 2026-10-31, https://aibio.space/companies/biostem-technologies/